Clinical Trial Update: Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating radiation therapy with paclitaxel and carboplatin in stage III non-small cell lung cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Radiation therapy

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-27